Abstract:Type I interferons (T1-IFN) are critical in the innate immune response, acting upon infected and uninfected cells to initiate an antiviral state by expressing genes that inhibit multiple stages of the lifecycle of many viruses. T1-IFN triggers the production of Interferon-Stimulated Genes (ISGs), activating an antiviral program that reduces virus replication. The importance of the T1-IFN response is highlighted by the evolution of viral evasion strategies to inhibit the production or action of T1-IFN in virus-infected cells. T1-IFN is produced via activation of pathogen sensors within infected cells, a process that is targeted by virus-encoded immunomodulatory molecules. This is probably best exemplified by the prototypic poxvirus, Vaccinia virus (VACV), which uses at least 6 different mechanisms to completely block the production of T1-IFN within infected cells in vitro. Yet, mice lacking aspects of T1-IFN signaling are often more susceptible to infection with many viruses, including VACV, than wild-type mice. How can these opposing findings be rationalized? The cytosolic DNA sensor cGAS has been implicated in immunity to VACV, but has yet to be linked to the production of T1-IFN in response to VACV infection. Indeed, there are two VACV-encoded proteins that effectively prevent cGAS-mediated activation of T1-IFN. We find that the majority of VACV-infected cells in vivo do not produce T1-IFN, but that a small subset of VACV-infected cells in vivo utilize cGAS to sense VACV and produce T1-IFN to protect infected mice. The protective effect of T1-IFN is not mediated via ISG-mediated control of virus replication. Rather, T1-IFN drives increased expression of CCL4, which recruits inflammatory monocytes that constrain the VACV lesion in a virus replication-independent manner by limiting spread within the tissue. Our findings have broad implications in our understanding of pathogen detection and viral evasion in vivo, and highlight a novel immune strategy to protect infected tissue.

MAVS, Cgas, and Endogenous Retroviruses in T-independent B Cell Responses

Autoimmune responses are dependent on the MAVS innate pathway due to its natural co-stimulating effect on B cell activation and maturation

T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms

Modified Vaccinia Virus Ankara Triggers Type I IFN Production in Murine Conventional Dendritic Cells via a cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway

Infection and Activation of B Cells by Theiler’s Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis

A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses

An Integrated Signaling Threshold Initiates IgG Response toward Virus-like Immunogens

Pivotal Roles of Cgas-Cgamp Signaling in Antiviral Defense and Immune Adjuvant Effects

Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses

A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity

Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden

MAVS Positively Regulates Mitochondrial Integrity and Metabolic Fitness in B Cells

STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection

Th17‐related Cytokines Contribute to Recall‐like Expansion/effector Function of HMBPP‐specific Vγ2Vδ2 T Cells after Mycobacterium Tuberculosis Infection or Vaccination

The endogenous Mtv8 locus and the immunoglobulin repertoire

Sequential MAVS and MyD88/TRIF signaling triggers anti-viral responses of tick-borne encephalitis virus-infected murine astrocytes

Anti-idiotypic Regulatory Responses Induced by Vaccination with DNA Encoding Murine TCR Valpha5 and Vbeta2.

VISA is Required for B Cell Expression of TLR7.

Toll-like Receptors 9 and 3 As Essential Components of Innate Immune Defense Against Mouse Cytomegalovirus Infection

B cell TLRs and induction of immunoglobulin class-switch DNA recombination

MAIT cell activation augments adenovirus vector vaccine immunogenicity